SEC Form 13F
| Report period | 2026-06-30 |
|---|---|
| Publicly available | 2026-08-15 |
| Reported value | $269,201,776 |
| Positions | 35 |
| Issuer | Ticker | Class | Reported value | Reported amount |
|---|---|---|---|---|
| DELCATH SYSTEMS, INC. | DCTH | COM NEW | $41,551,898 | 3,300,389 |
| FENNEC PHARMACEUTICALS INC | FENC | COM | $34,271,011 | 3,188,001 |
| XERIS BIOPHARMA HOLDINGS INC | XERS | COM | $23,039,130 | 2,908,981 |
| SAVARA INC | SVRA | COM | $19,577,225 | 3,178,121 |
| VERASTEM INC | VSTM | COM NEW | $15,228,464 | 3,986,509 |
| X4 PHARMACEUTICALS INC | XFOR | COM NEW | $15,012,957 | 3,214,766 |
| EYEPOINT PHARMACEUTICALS INC | EYPT | COM NEW | $14,131,689 | 988,230 |
| CYBIN INC | HELP | COM NEW | $12,934,541 | 1,956,814 |
| VOR BIOPHARMA INC | VOR | COM NEW | $11,940,726 | 648,600 |
| VAXCYTE INC | PCVX | COM | $11,626,000 | 200,000 |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.